** Shares of Cipla CIPL.NS gain ~6% so far this week, set for best week since July 2023
** Stock set to gain for sixth straight week
** Earlier this week, the drugmaker reported a weaker-than-expected fourth-quarter profit as sharp weakness in its U.S. business and higher costs outweighed strong domestic demand
** Analysts at Ambit Capital had said revenue and profitability have largely bottomed out, and gradual sequential improvement should be visible through FY27
** YTD, CIPL down ~5% vs ~9% fall in Nifty 50 index .NSEI
(Reporting by Vijay Malkar)
((VijayDattaram.Malkar@thomsonreuters.com;))